The health insurance funds (whether HEK and/or hkk participate in each lot is determined by the designation of the respective lot) aim to enter into discount contracts with all suitable pharmaceutical companies according to § 130a Abs. 8 SGB V for the active ingredients, combinations of active ingre
71 days left to bid. Opened 9 months ago, deadline 31 Oct 2026.
Only 2 prior awards here — too little to read.
In healthcare medical, TECHNIKER HEALTH INSURANCE has awarded 2 contracts to 2 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
This contract involves establishing substance-related discount agreements according to § 130a Abs. 8 SGB V for specific pharmaceuticals for a maximum period of 24 months, starting no earlier than January 1, 2027 (different start dates may apply based on the details provided for the affected lots). T
The contractor will supply calendars and promotional items to Techniker Krankenkasse (TK). All services will be provided in the contractor's name and upon request from TK.
This contract opportunity is for pharmaceutical companies to enter into discount agreements for the drug Epoetin beta, as part of the Open-House-Biologika process. The participating health insurance funds aim to establish uniform discount contracts without individual negotiations, ensuring no exclus
The health insurance funds (whether HEK and/or hkk participate in each lot is determined by the designation of the respective lot) aim to establish discount contracts with all suitable pharmaceutical companies according to § 130a Abs. 8 SGB V for the active ingredients, combinations of active ingred
Innovate UK is investing up to £25.4 million to help develop and test early cancer diagnostic technologies, particularly for less common cancers, with projects costing £1.5-£4 million over 24-36 months.
Innovate UK is offering up to £25.4 million to fund collaborative projects that clinically validate innovative early cancer diagnostic technologies and devices led by UK organisations including at least one SME.
UKHSA seeks supplier information for Doxycycline 10-pack supply through a preliminary market engagement exercise under the Procurement Act 2023.
Suppliers are invited to complete a preliminary market engagement questionnaire about patient diagnostic and monitoring electrodes by 21st September 2026 through eTendersNI.
